Lhasa Limited

shared knowledge shared progress

ABOUT US |
CONTACT US |
CAREERS |
Login

Related News

Nitrites in Excipients data release: Supporting more scientifically driven nitrosamine risk assessments
Lhasa Limited is pleased to announce the release of the 2022.1 Nitrites in Excipients database.
17 May 2022
Lhasa Limited’s Elemental Impurities Database is now open for all to join
29 April 2022
Vitic 2022.1 data release: A high quality source for toxicity data
10 February 2022

Related Blog Articles

Nitrites in Excipients Data Sharing Consortium: Supporting Nitrosamine Risk Assessment
Nitrite analysis of excipients is a new and analytically challenging area, with many organisations working quickly to determine the best practice and techniques to use.

The Nitrites in Excipients data sharing consortium was established in September 2020 and is part of Lhasa Limited's effort to support the global challenge of nitrosamine risk assessment.
22 February 2022
20 tips for nitrosamine impurity assessment
05 August 2021
The top 5 benefits of data sharing with Vitic [an infographic]
08 April 2021

Recent News

Nitrites in Excipients data release: Supporting more scientifically driven nitrosamine risk assessments
Lhasa Limited is pleased to announce the release of the 2022.1 Nitrites in Excipients database.
17 May 2022

Recent Blog Articles

5 things you should know about the data in the Lhasa Carcinogenicity Database (LCDB)
Would your toxicology assessments benefit from free access to long-term carcinogenicity study data? The Lhasa Carcinogenicity Database (LCDB) is a widely used, free resource of long-term carcinogenicity study data.

In this article we explore 5 things you should know about the data in the LCDB.
25 May 2022

Recent Publications

A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products
May 2022Nitrites in Excipients
An Evaluation of the Occupational Health Hazards of Peptide Couplers
May 2022Derek Nexus
Application of AOPs for Weight-of-Evidence Assessments: Rationalising Evidence for the ICH S1B(R1) Guidance Addendum
April 2022Kaptis

Upcoming Events

Recent News

Nitrites in Excipients data release: Supporting more scientifically driven nitrosamine risk assessments
Lhasa Limited is pleased to announce the release of the 2022.1 Nitrites in Excipients database.
17 May 2022
Lhasa Limited announces the anticipated launch of Federated Learning Hackathon
03 May 2022
Lhasa Limited’s Elemental Impurities Database is now open for all to join
29 April 2022

Recent Blog Articles

5 things you should know about the data in the Lhasa Carcinogenicity Database (LCDB)
Would your toxicology assessments benefit from free access to long-term carcinogenicity study data? The Lhasa Carcinogenicity Database (LCDB) is a widely used, free resource of long-term carcinogenicity study data.

In this article we explore 5 things you should know about the data in the LCDB.
25 May 2022
Is expert review an essential step when assessing mutagenic potential of drug impurities?
05 May 2022
Controlling potentially mutagenic impurities – 8 top tips from industry experts
04 April 2022

Archive

This is a library of Lhasa's blog articles.

5 minutes
Effiris: A secondary pharmacology model suite powered by privacy-preserving data sharing
Artificial Intelligence (AI) has become a powerful force within the pharmaceutical industry, catalysed by the challenging lengthy and costly drug development process. To maximize the impact of AI, it is critical to have access to enough good quality data to allow machine learning algorithms to extract relevant knowledge and produce valuable models.
- Innovation
21 May 2020

Sitemap

© 2022 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.